Ensure that your key investments have the right comparators, endpoints and patient data​.

phase 3 design criteria.

Get your clinical decisions right so that market access, pricing and launch uptake are optimised, creating the evidence that payers and insurers want.  

The challenge: Ensuring that your phase 3 programme has the right comparators, endpoints, outcome measures and patient data collection methods is critical.  

The solution: Our technology-driven approach allows us to look at competitor studies, technology analogues, evolving HTA requirements, endpoints, investigators, academic centres and more, giving you the most comprehensive picture possible, tailored to your specific needs.


  • Top global KOLs down to sub-speciality, so you can speak with the right people​
  • Comparator evaluation – what has been used, selected (prospective) or gap analysis from prior submissions​
  • Patient data collection requirements – gap analysis, payer requirements and areas that require intervention​

No items found.
View this case study

All delivered as strategic reports, interactive intelligence dashboards and scenario planning tools, placing an optimal strategy at your fingertips.